Cargando…

Are DDX41 variants of unknown significance and pathogenic variants created equal?

Detalles Bibliográficos
Autores principales:	Xie, Zhuoer, Starczynowski, Daniel T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620556/ https://www.ncbi.nlm.nih.gov/pubmed/37317927 http://dx.doi.org/10.3324/haematol.2023.283416

Ejemplares similares

P442: DDX41 GERMLINE VARIANTS: POPULATION PREVALENCE, SIGNIFICANCE AND LEUKEMIC EVOLUTION
por: Cheloor Kovilakam, Sruthi, et al.
Publicado: (2023)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms
por: Badar, Talha, et al.
Publicado: (2023)

Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia
por: Cardoso, S R, et al.
Publicado: (2016)

"ALL ANTIDEPRESSANTS ARE CREATED EQUAL" (SOME ARE MORE EQUAL THAN OTHERS)
por: Doongaji, Dinshaw R
Publicado: (2000)

Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
por: Hoppe, Kerstin, et al.
Publicado: (2021)

Computational and biophysical determination of pathogenicity of variants of unknown significance in cardiac thin filament
por: Mason, Allison B., et al.
Publicado: (2021)

Cytogenetic alterations in CML: not all created equal
por: Gong, Zimu, et al.
Publicado: (2018)

DDX41-associated susceptibility to myeloid neoplasms
por: Makishima, Hideki, et al.
Publicado: (2023)

Removing uncertainty from variants of unknown significance
por: McNally, Elizabeth M.
Publicado: (2023)

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
por: Homan, Claire C., et al.
Publicado: (2023)

Are all metachronous multifocal urothelial carcinoma created equal?
por: Reis, Leonardo O.
Publicado: (2018)

Not All EGFR Exon 20 Insertions Are Created Equal
por: Lin, Yen-Ting, et al.
Publicado: (2020)

Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance
por: van Lint, F. H. M., et al.
Publicado: (2019)

Current Understanding of DDX41 Mutations in Myeloid Neoplasms
por: Kim, Kunhwa, et al.
Publicado: (2023)

The emerging roles of the DDX41 protein in immunity and diseases
por: Jiang, Yan, et al.
Publicado: (2016)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern: the knowns and unknowns
por: Lessells, Richard J.
Publicado: (2021)

MicroRNA Based Treatment of Cardiomyopathy: Not all Dystrophies are Created Equal
por: Rodino‐Klapac, Louise R.
Publicado: (2013)

Not All Insults Are Created Equal for Awakening Dormant Stem Cell Abilities
por: Vega, Paige N., et al.
Publicado: (2019)

Structural and functional analyses of human DDX41 DEAD domain
por: Jiang, Yan, et al.
Publicado: (2016)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

Actionability classification of variants of unknown significance correlates with functional effect
por: Johnson, Amber, et al.
Publicado: (2023)

Computational and experimental methods for classifying variants of unknown clinical significance
por: Spielmann, Malte, et al.
Publicado: (2022)

From variant of unknown significance to likely pathogenic: Characterization and pathogenicity determination of a large genomic deletion in the MLH1 gene
por: Bouras, Ahmed, et al.
Publicado: (2023)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

Erratum to: Structural and functional analyses of human DDX41 DEAD domain
por: Jiang, Yan, et al.
Publicado: (2017)

The known unknown: the challenges of genetic variants of uncertain significance in clinical practice
por: Hoffman-Andrews, Lily
Publicado: (2018)

Characterizing variants of unknown significance in rhodopsin: A functional genomics approach
por: Wan, Aliete, et al.
Publicado: (2019)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Ikegami, Masachika, et al.
Publicado: (2020)

Hereditary variants of unknown significance in African American women with breast cancer
por: McDonald, J. Tyson, et al.
Publicado: (2022)

DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
por: Rolles, Benjamin, et al.
Publicado: (2023)

PB1819: KMT2A::ARHGEF12 RARE FUSION ASSOCIATED WITH A NOVEL GERMLINE DDX41 VARIANT IN ACUTE MYELOID LEUKEMIA
por: Roubinet, Maxime, et al.
Publicado: (2023)

Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants
por: Ma, Kai Yu, et al.
Publicado: (2021)

Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart
por: Lymperopoulos, Anastasios, et al.
Publicado: (2019)

This variant alters protein function, but is it pathogenic?
por: Pandolfo, Massimo
Publicado: (2017)

Variants of Uncertain Significance and “Missing Pathogenicity”
por: Fatkin, Diane, et al.
Publicado: (2020)

Upgrading an intronic TMEM67 variant of unknown significance to likely pathogenic through RNA studies and community data sharing
por: Kurolap, Alina, et al.
Publicado: (2022)

Not all vinculins are created equal
por: Leslie, Mitch
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_frofknovtndj2bsagjianf72kn